Dianthus Therapeutics Inc
DNTH
NASDAQ
Biotechnology
$115.96
USD
+6.36 (+5.80%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.19B
Volume 897.2K
Price Target
$158.00 – $158.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $158.00 and a min estimate of $158.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$158.00
+$27.2 vs prior
Implied Upside
+36.3%
+23.4% vs prior
Analyst Covering
1
-9 vs prior period
Consensus
Buy
Declined vs prior
Signal Quality
Consensus Freshness
9%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Swayampakula Ramakanth | HC Wainwright & Co. | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TVTX
Travere Therapeutics Inc
$62.14
▲ +1.2%
SRRK
Scholar Rock Holding Corp
$52.52
▼ -1.0%
CAI
Caris Life Sciences Inc
$21.80
▼ -1.7%
MIRM
Mirum Pharmaceuticals Inc
$100.64
▲ +1.9%
ERAS
Erasca Inc
$18.38
▲ +2.9%
PTCT
PTC Therapeutics Inc
$71.70
▼ -0.4%
CGON
CG Oncology Inc
$75.03
▲ +0.4%
COGT
Cogent Biosciences Inc
$37.93
▲ +1.7%